Politics and Solutions . . . Health insurance cage for birds set harvest frequency now floor price a batch of drugs to accelerate the exit!

In August, the autumn wind comes, wait for autumn to come.
this month, the national health-care directory adjustment plan was formally finalized.
The scope of adjustment of this medical insurance catalogue is included in the scope of new drugs listed before the date of the announcement of the plan (August 17), clinically in urgent need of drugs and "more than 5 provinces recognized" drugs need to be included in the scope of medicines in the medical insurance catalogue, and also stressed that a number of drugs will be kicked out.
the adjustment of the medical insurance catalogue will accelerate the release of new drugs, help high clinical value drugs to increase market share, and clinically ineffective drugs will be gradually cleared out of the market.
addition, the third batch of national harvests, which have attracted much attention in the industry, arrived on schedule.
from the results of the selection, the collection of 56 varieties of only Rafmi fixed flow mark, a total of 191 products selected, involving 125 enterprises, the highest decline of 98.72 percent, an average decline of about 70.52 percent.
, compared with the first two rounds of collection, the price reduction of this collection is greater, the minimum unit price of many drugs to 1 cent.
, the domestic generic drug companies bid ferociously, the participation of the original pharmaceutical companies significantly reduced, only 3 foreign enterprises were selected.
domestic generic drug replacement of the original research drug accelerated.
The other side of the local collection is also moving forward in the exploration, such as Shanghai belt procurement requirements multi-party linkage, non-state-owned varieties and other band bargaining, Henan collection to take tender procurement and bargaining negotiations, Hainan Province on the un-evaluated generic drugs "knife", with volume procurement continues to upgrade.
With the continuous promotion of volume procurement and adjustment of medical insurance catalogues, the payment space for generic drugs and drugs with low clinical value has been compressed, the payment of innovative drugs and clinically essential drugs has been improved, the pharmaceutical industry has accelerated the "cage-for-bird" and the upgrading of industrial structure has accelerated.
and a few rounds of collection down, the health care catalog dynamic adjustment ... Pharmaceuticals also seem to be calming down about changes in the industry.
This month's heavyweight point of view is: by the end of 2022 Hebei Province, the original increase of Class B drugs will be all transferred out;